SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001511164-12-000102
Filing Date
2012-05-15
Accepted
2012-05-15 14:00:47
Documents
11
Period of Report
2012-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A neurokineform10kajan3112.htm 10-K/A 717371
2 EXHIBIT 31.1 exhibit311.htm EX-31 7578
3 EXHIBIT 31.2 exhibit312.htm EX-31 7600
4 EXHIBIT 32.1 exhibit321.htm EX-32 5629
5 EXHIBIT 32.2 exhibit322.htm EX-32 5610
  Complete submission text file 0001511164-12-000102.txt   2399194

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT neukf-20120131.xml EX-101.INS 301504
7 XBRL TAXONOMY EXTENSION SCHEMA neukf-20120131.xsd EX-101.SCH 21970
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE neukf-20120131_cal.xml EX-101.CAL 6650
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE neukf-20120131_def.xml EX-101.DEF 61071
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE neukf-20120131_lab.xml EX-101.LAB 105766
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE neukf-20120131_pre.xml EX-101.PRE 76778
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Neurokine Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 333-161157 | Film No.: 12843180
SIC: 2834 Pharmaceutical Preparations